Both in Biotechnology
Taysha Gene Therapies vs Inhibrx Biosciences
Over the past year TSHA returned +57.9% and INBX returned +224.5%; their daily moves had a correlation of 0.16.
TSHA +57.9% INBX +224.5%Growth of $1, one year, split-adjusted
| Metric | TSHA | INBX |
|---|---|---|
| Price | $4.99 | $104.83 |
| Market cap | $1.63B | $1.54B |
| Today | 0.00% | +3.07% |
| 1 month | −13.5% | −15.1% |
| 6 months | +22.6% | +75.1% |
| Year to date | −9.3% | +32.7% |
| 1 year | +53.5% | +220.8% |
| Revenue growth (YoY) | −100.0% | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 296.4× | — |
| Net cash | $406.1M | -$42.9M |
| Dividend yield | — | — |
| Volatility (60d) | 62.0% | 67.6% |
| Short % of float | 20.1% | 36.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).